Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 59,000 CTMX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 59,000 | n/a |
| May 26, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 17,084 | n/a |
| Nov 26, 2025 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 25,000 | n/a |
| Jun 16, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 25,000 | n/a |
| Jun 13, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jun 6, 2024 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 25,000 | n/a |
| May 24, 2024 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 67,000 | n/a |
| May 17, 2024 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jun 16, 2023 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 25,000 | n/a |
| Jun 5, 2023 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 13,900 | n/a |